The theory is that these effects would occur regardless of whether the substance is alcohol, drugs, or nicotine
In simple terms, it means using smaller doses than the recommended starting dose, or not escalating the dosing until you reach a maintenance dose (which is the standard practice used in clinical trials)
Unlike pharmaceutical sleep aids that cause next-day drowsiness, cognitive impairment, tolerance, and dependency, DSIP enhances sleep quality without sedative side effects, maintains normal sleep architecture, causes no morning grogginess, develops no tolerance requiring dose escalation, and demonstrates no withdrawal symptoms or addiction potential
Gene expression on BDNF and SK-3 was quantified using real-time PCR, revealing that VPA reduced the expression BDNF, which plays a crucial role in synaptic plasticity and neuronal survival, and increased GSK-3, which is involved in neurodevelopment and neuroinflammation whereas crocin dose-dependently normalized both markers ( Weight of evidence: Overall evidence is LowModerate in VPA models
